NO983217L - Terapeutiske anti-astmamidler som inneholder selenforbindeler - Google Patents

Terapeutiske anti-astmamidler som inneholder selenforbindeler

Info

Publication number
NO983217L
NO983217L NO983217A NO983217A NO983217L NO 983217 L NO983217 L NO 983217L NO 983217 A NO983217 A NO 983217A NO 983217 A NO983217 A NO 983217A NO 983217 L NO983217 L NO 983217L
Authority
NO
Norway
Prior art keywords
agents containing
agent
containing selenium
therapeutic anti
selenium compounds
Prior art date
Application number
NO983217A
Other languages
English (en)
Other versions
NO983217D0 (no
Inventor
Yoshiyuki Uchida
Akira Akashi
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO983217D0 publication Critical patent/NO983217D0/no
Publication of NO983217L publication Critical patent/NO983217L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO983217A 1996-01-26 1998-07-13 Terapeutiske anti-astmamidler som inneholder selenforbindeler NO983217L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1184896 1996-01-26
PCT/DE1997/000135 WO1997026968A2 (de) 1996-01-26 1997-01-27 Therapeutische mittel, enthaltend organische selenverbindungen gengen asthma

Publications (2)

Publication Number Publication Date
NO983217D0 NO983217D0 (no) 1998-07-13
NO983217L true NO983217L (no) 1998-09-25

Family

ID=11789151

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983217A NO983217L (no) 1996-01-26 1998-07-13 Terapeutiske anti-astmamidler som inneholder selenforbindeler

Country Status (20)

Country Link
EP (1) EP0876144B1 (no)
CN (1) CN1116876C (no)
AT (1) ATE207746T1 (no)
AU (1) AU728713B2 (no)
BR (1) BR9707303A (no)
CA (1) CA2244085C (no)
CZ (1) CZ292670B6 (no)
DE (2) DE19780042D2 (no)
DK (1) DK0876144T3 (no)
EA (1) EA001066B1 (no)
ES (1) ES2165034T3 (no)
HK (1) HK1019862A1 (no)
HU (1) HUP9901639A3 (no)
IL (1) IL124006A (no)
NO (1) NO983217L (no)
NZ (1) NZ330198A (no)
PL (1) PL187620B1 (no)
PT (1) PT876144E (no)
TR (1) TR199801398T2 (no)
WO (1) WO1997026968A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
CA2368484A1 (en) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrates for thioredoxin reductase
KR20110136813A (ko) 2009-03-17 2011-12-21 다이이찌 산쿄 가부시키가이샤 아미드 유도체
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105622478B (zh) * 2014-10-27 2017-08-25 中国科学院大连化学物理研究所 3,3‑二烷硫基‑2‑苯硒基‑2‑丙烯‑1‑酮衍生物及合成
CN109627198B (zh) * 2019-02-01 2020-11-10 河南科技大学 一种2-丙酮基硒基苯甲酰胺类化合物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778814A (en) * 1987-03-18 1988-10-18 Ciba-Geigy Corporation Method of treating ocular allergy by topical application of a 2-substituted-1,2-benzisoselenazol-3(2H)-one
DZ1460A1 (fr) * 1989-11-22 2004-09-13 Sod Conseils Rech Applic Nouveaux dérivés du sélénophèn ainsi que leur procédé de préparation.
IT1250751B (it) * 1991-08-02 1995-04-21 Boehringer Mannheim Italia (3h,7h)selenazolo(3,4-a|piridine con attivita' antiasmatica ed antiinfiammatoria delle vie aereea
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤
DE19506669A1 (de) * 1995-02-25 1996-08-29 Nattermann A & Cie Lipoxygenasehemmer

Also Published As

Publication number Publication date
AU728713B2 (en) 2001-01-18
EA199800658A1 (ru) 1999-02-25
IL124006A (en) 2004-07-25
HK1019862A1 (en) 2000-03-03
PL187620B1 (pl) 2004-08-31
DE19780042D2 (de) 1999-01-28
CZ292670B6 (cs) 2003-11-12
EP0876144B1 (de) 2001-10-31
ATE207746T1 (de) 2001-11-15
CZ235698A3 (cs) 1999-04-14
BR9707303A (pt) 2000-05-02
PT876144E (pt) 2002-04-29
CA2244085C (en) 2008-10-14
TR199801398T2 (xx) 1998-10-21
CA2244085A1 (en) 1997-07-31
AU2149797A (en) 1997-08-20
CN1219127A (zh) 1999-06-09
WO1997026968A3 (de) 1997-09-25
NZ330198A (en) 2000-06-23
WO1997026968A2 (de) 1997-07-31
PL328198A1 (en) 1999-01-18
HUP9901639A3 (en) 2000-10-30
ES2165034T3 (es) 2002-03-01
EP0876144A2 (de) 1998-11-11
CN1116876C (zh) 2003-08-06
DK0876144T3 (da) 2002-02-25
EA001066B1 (ru) 2000-10-30
NO983217D0 (no) 1998-07-13
HUP9901639A1 (hu) 1999-09-28
DE59705183D1 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
NO974163L (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
WO1999063826A3 (de) Mittel zur bekämpfung von pflanzenschädlingen
CA2260337A1 (en) Therapeutic agents
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
NO983217D0 (no) Terapeutiske anti-astmamidler som inneholder selenforbindeler
EA200100140A1 (ru) Терапевтическая композиция на основе флавоноидов для применения в лечении опухолей цитотоксическими агентами
DE69825977D1 (de) Antivirale mittel
DE69825981D1 (de) 4,5-dihydroxy-2-cyclopenten-1-on für die Behandlung von Diabetes Mellitus
EP1325748A4 (en) PROPHYLACTIC OR THERAPEUTIC DRUGS AGAINST CANCER CONTAINING CYANIDINE COMPOUNDS AS AN ACTIVE AGENT
DK0632717T3 (da) Middel til anvendelse som et anti-irritationsmiddel
NO20003138L (no) Ny anvendelse av lokalanestetika mot vaskulære hodepiner
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
BR9814815A (pt) Agente para o tratamento de leishmaniose com um derivado de glicopiranose como ingrediente eficaz
RU94022757A (ru) Агент торможения агрегации тромбоцитов
ZA200205567B (en) Quaternary ammonium and their use as anti-tussive agent.
TH36624A (th) วิธีการและองค์ประกอบสำหรับการเพิ่มกัมมันภาพของสารฆ่าจุลินทรีย์

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application